| Entry |
|
|---|
| Name |
Molidustat (USAN/INN) |
|---|
| Formula |
C13H14N8O2
|
|---|
| Exact mass |
314.1240
|
|---|
| Mol weight |
314.30
|
|---|
| Structure |
|
|---|
| Remark |
| Product (DG03157): | D11273<JP> |
|
|---|
| Efficacy |
Anti-anemic, Hypoxia inducible factor-prolyl hydroxylase (HIF-PH) inhibitor |
|---|
| Comment |
Management of anemia associated with chronic kidney disease in cats
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B03 ANTIANEMIC PREPARATIONS
B03X OTHER ANTIANEMIC PREPARATIONS
B03XA Other antianemic preparations
B03XA09 Molidustat
D12122 Molidustat (USAN/INN)
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
HIF hydroxylase
EGLN (HPH)
D12122 Molidustat (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 23
1 C8y C 17.7389 -18.2297
2 N5x N 17.7389 -19.6320
3 C8x C 19.0010 -20.3332
4 N5x N 20.1929 -19.6320
5 C8y C 20.1929 -18.2297
6 C8x C 19.0010 -17.5286
7 N1y N 21.4550 -17.5286
8 C1x C 22.6469 -18.2297
9 C1x C 23.8389 -17.5286
10 O2x O 23.8389 -16.1263
11 C1x C 22.6469 -15.4251
12 C1x C 21.4550 -16.1263
13 N4y N 16.5470 -17.5286
14 C8y C 16.5470 -16.1263
15 C8y C 15.2148 -15.7056
16 C8x C 14.3734 -16.8274
17 N5x N 15.2148 -17.9493
18 N4y N 14.7941 -14.3734
19 C8x C 15.6355 -13.2516
20 C8x C 14.8642 -12.1297
21 N5x N 13.5320 -12.5504
22 N5x N 13.4619 -13.9527
23 O1a O 17.6707 -15.3026
BOND 26
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 5 7 1
8 7 8 1
9 8 9 1
10 9 10 1
11 10 11 1
12 11 12 1
13 7 12 1
14 1 13 1
15 13 14 1
16 14 15 2
17 15 16 1
18 16 17 2
19 13 17 1
20 15 18 1
21 18 19 1
22 20 21 1
23 21 22 2
24 18 22 1
25 19 20 2
26 14 23 1
|
|---|
